Trial intelligence / Profile preview

AZARGA as Replacement Therapy for COMBIGAN in Glaucoma/OHT

NCT01415401Phase 4Completed

Sponsor
Alcon Inc.
Start
Sep 2011
Primary completion
Jun 2013
Modality
Small Molecules
01

Overview

A Phase 4 trial of brinzolamide in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Sep 2011; status: completed.

02

Drugs

brinzolamide
03

Conditions

open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on NCT01415401.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01415401.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call